DHR — Danaher Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Danaher, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2019 December 31st	2020 December 31st	R2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	17,911	22,284	24,802	26,643	23,890
Cost of Revenue
Gross Profit	9,984	12,475	15,239	16,188	14,034
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	14,649	17,624	18,516	19,016	18,657
Operating Profit	3,262	4,660	6,286	7,627	5,233
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	3,305	4,495	6,511	7,146	5,044
Provision for Income Taxes
Net Income After Taxes	2,432	3,646	5,447	6,328	4,221
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	3,008	3,646	6,433	7,209	4,764
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	2,942	3,511	6,347	7,123	4,743
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.17	4.33	7.42	8.37	5.9
Dividends per Share